# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Neurofibromatosis type 2

Neurofibromatosis 2 (NF2)Bilateral Acoustic NeurofibromatosisBANF Acoustic Neurinoma
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 16 results.
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Status: Recruiting
Last Changed: Jul 23, 2020
First Received: Feb 25, 2020
Disease(s): Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS)
Intervention(s): Crizotinib
Locations: The University of Alabama at Birmingham (Site 700), Birmingham, Alabama, United States
Univ of California @ Los Angeles (Site 325), Los Angeles, California, United States
Children's National Medical Center (Site 775), Washington, District of Columbia, United States
Children's HealthCare of Atlanta (Site 950), Atlanta, Georgia, United States
Lurie Children's Hospital of Chicago (Site 350), Chicago, Illinois, United States
... and 13 other locations.
A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
Status: Recruiting
Last Changed: Jan 07, 2020
First Received: Sep 17, 2018
Disease(s): Neurofibromatosis 1 and 2 (NF1 and NF2)
Intervention(s): hand-held dynamometer
Locations: New York School of Medicine, New York, New York, United States
Natural History Study of Patients With Neurofibromatosis Type 2
Status: Recruiting
Last Changed: Jul 20, 2020
First Received: Jan 21, 2008
Disease(s): Neurofibromatosis
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2
Status: Recruiting
Last Changed: Jul 15, 2020
First Received: May 05, 2020
Disease(s): Neurofibromatosis Type 2, Vestibular Schwannoma, Non-vestibular Schwannoma, Meningioma, Ependymoma
Intervention(s): Brigatinib
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
Status: Recruiting
Last Changed: Jun 05, 2020
First Received: Mar 29, 2017
Disease(s): Neurofibromatosis 2, Vestibular Schwannoma, Meningioma, Ependymoma, Glioma
Intervention(s): Selumetinib
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
Status: Recruiting
Last Changed: Mar 28, 2019
First Received: Mar 28, 2019
Disease(s): Neurofibromatosis 2, Dermatology/Skin - Other
Intervention(s): no intervention
Locations: Nice Hospital, Nice, France
Resiliency Training in Adolescents With NF1 and NF2
Status: Recruiting
Last Changed: Dec 02, 2019
First Received: Mar 13, 2019
Disease(s): Neurofibromatoses
Intervention(s): Stress and Symptom Management Program 1, Stress and Symptom Management Program 2
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Neurofibromatosis (NF) Registry Portal
Status: Recruiting
Last Changed: Jul 22, 2020
First Received: Jun 25, 2013
Disease(s): Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Locations: Children's Tumor Fundation, New York, New York, United States
Study of Aspirin in Patients With Vestibular Schwannoma
Status: Recruiting
Last Changed: Aug 09, 2019
First Received: Mar 15, 2017
Disease(s): Vestibular Schwannoma, Acoustic Neuroma, Neurofibromatosis 2
Intervention(s): Aspirin, Placebo
Locations: Stanford Otolaryngology/HNS, Stanford, California, United States
University of Iowa, Iowa City, Iowa, United States
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
... and 2 other locations.
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
Status: Recruiting
Last Changed: Jan 23, 2018
First Received: Jan 23, 2018
Disease(s): Neurofibromatoses, Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Intervention(s): Stress and Symptom Management Program 1, Stress and Symptom Management Program 2
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States